TheProfitWatch

XERS - Xeris Biopharma Holdings, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
7.13 -0.3 (-4.21%) 0.0 (0.0%) -0.01 (-0.15%) -0.04 (-0.65%) -0.28 (-3.93%) 0.01 (0.15%) 0.14 (1.96%) -0.28 (-3.93%)

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.01
Diluted EPS:
-0.01
Basic P/E:
-683.0
Diluted P/E:
-683.0
RSI(14) 1m:
53.33
VWAP:
6.83
RVol:

Events

Period Kind Movement Occurred At

Related News